Psoriatic arthritis

Study

We are conducting a study on psoriatic arthritis that is observational. Your treatment and medical care will not change if you participate in this study. In other words, you will continue with the same treatment included in your medical care (you will not be given any additional study drugs).

Observational research studies only collect and document information about medical treatment and care. No experimental treatment is evaluated and no additional clinic visit is required.

You may be eligible to participate in the study if:

  • You have a new prescription for your rheumatic fever to treat your psoriatic arthritis.
  • You have been diagnosed with psoriatic arthritis for at least 6 months.
  • You are between 18 and 80 years old, inclusive.

I want to apply to this clinical study

Sherbrooke

For more information, contact us at 819 346-2887 (Sherbrooke) or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.